TRENTON, N.J. (AP) — A nonprescription version of Nexium, the most popular medicine for frequent, severe heartburn, has just gone on sale. Drugmaker Pfizer Inc. said Tuesday that over-the ...

Pfizer bought the over-the-counter rights to Nexium from AstraZeneca in 2012 for $250 million, and Nexium 24HR was approved by the FDA for sale in 2014, the same year prescription Nexium went off ...

Britain's AstraZeneca has agreed to pay $425 million to settle about 11,000 lawsuits in the United States that claimed its heartburn drugs Nexium and Prilosec caused chronic kidney disease.

Pharmaceutical company AstraZeneca said Tuesday it will pay $425 million to settle lawsuits from people who experienced kidney damage from the company’s heartburn medications Nexium and Prilosec.

(RTTNews) - Perrigo Company plc (PRGO) said that it has received final approval from the U.S. Food & Drug Administration for the store brand OTC equivalent of Nexium 24HR or esomeprazole magnesium ...

Did AstraZeneca make a huge mistake in turning down Pfizer, or does management have a good, strong sustainable growth plan coming up? S&P 500 +---% | Stock Advisor +---% Join ...

NEW YORK — Pfizer's Nexium 24HR will launch May 27, Pfizer reported in a conference call Monday. "[The Nexium] approval represents the first significant milestone in executing our Rx-to-OTC ...

Perrigo Company plc PRGO announced that the FDA has granted a final approval to the over-the-counter (OTC) version of AstraZeneca's AZN Nexium 24HR.

A nonprescription version of Nexium, the most popular medicine for frequent, severe heartburn, has just gone on sale. Drugmaker Pfizer Inc. said Tuesday that over-the-counter Nexium 24HR is ...

AstraZeneca will manufacture the nonprescription version for Pfizer and continue selling prescription ... The Food and Drug Administration approved over-the-counter Nexium 24HR two months ago.

Pharmaceutical company AstraZeneca said Tuesday it will pay $425 million to settle lawsuits from people who experienced kidney damage from the company’s heartburn medications Nexium and Prilosec.

DUBLIN, Aug. 21, 2017 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has received final approval from the U.S. Foo ...